β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt.

[1]  J. Violin,et al.  GPCR biased ligands as novel heart failure therapeutics. , 2013, Trends in cardiovascular medicine.

[2]  P. Widimsky,et al.  Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome Patients , 2013, PloS one.

[3]  F. Wang,et al.  Cardiotoxic and Cardioprotective Features of Chronic &bgr;-Adrenergic Signaling , 2013, Circulation research.

[4]  A. Gödecke,et al.  Expression of the murine Nr4a1 gene is controlled by three distinct genomic loci. , 2013, Gene.

[5]  R. Roskoski.  ERK1/2 MAP kinases: structure, function, and regulation. , 2012, Pharmacological research.

[6]  A. Lochner,et al.  The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation , 2012, Basic Research in Cardiology.

[7]  D. Kass,et al.  Animal models of heart failure: a scientific statement from the American Heart Association. , 2012, Circulation research.

[8]  M. Rossner,et al.  Regulation of the EGF Transcriptional Response by Endocytic Sorting , 2012, Science Signaling.

[9]  S. Houser,et al.  A Caveolae-Targeted L-Type Ca2+ Channel Antagonist Inhibits Hypertrophic Signaling Without Reducing Cardiac Contractility , 2012, Circulation research.

[10]  Zhiwei Xu,et al.  β2‐Adrenergic receptor‐induced transactivation of epidermal growth factor receptor and platelet‐derived growth factor receptor via Src kinase promotes rat cardiomyocyte survival , 2012, Cell biology international.

[11]  Hongying Shen,et al.  Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane , 2012, Proceedings of the National Academy of Sciences.

[12]  Suman Dalal,et al.  β-Adrenergic receptor stimulation induces endoplasmic reticulum stress in adult cardiac myocytes: role in apoptosis , 2012, Molecular and Cellular Biochemistry.

[13]  P. Juin,et al.  Serum-Nutrient Starvation Induces Cell Death Mediated by Bax and Puma That Is Counteracted by p21 and Unmasked by Bcl-xL Inhibition , 2011, PloS one.

[14]  D. Tilley.  G Protein–Dependent and G Protein–Independent Signaling Pathways and Their Impact on Cardiac Function , 2011, Circulation research.

[15]  S. Kjeldsen,et al.  The role of beta-blockers in the treatment of chronic heart failure. , 2011, Trends in pharmacological sciences.

[16]  S. Bandinelli,et al.  Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults. , 2011, Atherosclerosis.

[17]  A. Lochner,et al.  The Role of β-adrenergic Receptors in the Cardioprotective Effects of Beta-Preconditioning (βPC) , 2011, Cardiovascular Drugs and Therapy.

[18]  L. Jaffe,et al.  Epidermal growth factor receptor kinase activity is required for gap junction closure and for part of the decrease in ovarian follicle cGMP in response to LH. , 2010, Reproduction.

[19]  S. Houser,et al.  {beta}1-Adrenergic receptor activation induces mouse cardiac myocyte death through both L-type calcium channel-dependent and -independent pathways. , 2010, American journal of physiology. Heart and circulatory physiology.

[20]  R. Ferrari,et al.  An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. , 2010, Atherosclerosis.

[21]  J. Molkentin,et al.  Extracellular signal‐regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy , 2010, Annals of the New York Academy of Sciences.

[22]  C. Methner,et al.  Cardioprotection of bradykinin at reperfusion involves transactivation of the epidermal growth factor receptor via matrix metalloproteinase‐8 , 2009, Acta physiologica.

[23]  I. Madshus,et al.  Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking , 2009, Journal of Cell Science.

[24]  A. Ribeiro,et al.  Plasma concentrations of tumour necrosis factor‐alpha, tumour necrosis factor‐related apoptosis‐inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction , 2009, European journal of heart failure.

[25]  Priyesh A. Patel,et al.  β-Arrestin Mediates β1-Adrenergic Receptor-Epidermal Growth Factor Receptor Interaction and Downstream Signaling* , 2009, The Journal of Biological Chemistry.

[26]  M. Miączyńska,et al.  Signaling from endosomes: location makes a difference. , 2009, Experimental cell research.

[27]  Y. Tesfaigzi,et al.  How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? , 2009, Cell cycle.

[28]  S. Volpato,et al.  Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction , 2009, PloS one.

[29]  K. Huber,et al.  Prognostic value of apoptosis markers in advanced heart failure patients. , 2008, European heart journal.

[30]  J. Violin,et al.  β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation , 2008, Proceedings of the National Academy of Sciences.

[31]  Trenton L. Place,et al.  EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate. , 2008, The Biochemical journal.

[32]  J. Violin,et al.  β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection , 2007 .

[33]  M. von Zastrow,et al.  Signaling on the endocytic pathway. , 2007, Current opinion in cell biology.

[34]  S. Felix,et al.  The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation. , 2007, American journal of physiology. Heart and circulatory physiology.

[35]  K. Barrett,et al.  Consequences of Direct Versus Indirect Activation of Epidermal Growth Factor Receptor in Intestinal Epithelial Cells Are Dictated by Protein-tyrosine Phosphatase 1B* , 2007, Journal of Biological Chemistry.

[36]  T. Hébert,et al.  Functional beta-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. , 2006, Cardiovascular research.

[37]  J. Blenis,et al.  MAPK signal specificity: the right place at the right time. , 2006, Trends in biochemical sciences.

[38]  R. Seger,et al.  The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions , 2006, Growth factors.

[39]  A. Gerdes,et al.  Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes. , 2005, Journal of molecular and cellular cardiology.

[40]  Neal Rosen,et al.  The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. , 2005, Cancer cell.

[41]  Quan Chen,et al.  Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis. , 2005, Life sciences.

[42]  Kunio Kondoh,et al.  Control of MAP kinase signaling to the nucleus , 2005, Chromosoma.

[43]  M. Mocanu,et al.  Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. , 2005, American journal of physiology. Heart and circulatory physiology.

[44]  G. Zauli,et al.  Emerging non‐apoptotic functions of tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL)/Apo2L , 2004, Journal of cellular physiology.

[45]  L. Pelkmans,et al.  Not just a sink: endosomes in control of signal transduction. , 2004, Current opinion in cell biology.

[46]  H. Hollema,et al.  Tissue Distribution of the Death Ligand TRAIL and Its Receptors , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[47]  David A Hildeman,et al.  ×Phosphorylation of Bax Ser184 by Akt Regulates Its Activity and Apoptosis in Neutrophils* , 2004, Journal of Biological Chemistry.

[48]  J. Downey,et al.  Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF. , 2004, Journal of molecular and cellular cardiology.

[49]  R. Dickson,et al.  Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells. , 2003, Experimental cell research.

[50]  H. V. van Vlijmen,et al.  Identification of a New Murine Tumor Necrosis Factor Receptor Locus That Contains Two Novel Murine Receptors for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)* , 2003, The Journal of Biological Chemistry.

[51]  S. R. Datta,et al.  Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. , 2002, Developmental cell.

[52]  Zhixiang Wang,et al.  Endosomal Signaling of Epidermal Growth Factor Receptor Stimulates Signal Transduction Pathways Leading to Cell Survival , 2002, Molecular and Cellular Biology.

[53]  W. Koch,et al.  β-Adrenergic Receptor-mediated DNA Synthesis in Cardiac Fibroblasts Is Dependent on Transactivation of the Epidermal Growth Factor Receptor and Subsequent Activation of Extracellular Signal-regulated Kinases* , 2002, The Journal of Biological Chemistry.

[54]  K. Makino,et al.  Nuclear localization of EGF receptor and its potential new role as a transcription factor , 2001, Nature Cell Biology.

[55]  A. Sorkin.  Internalization of the epidermal growth factor receptor: role in signalling. , 2001, Biochemical Society transactions.

[56]  P. Scheurich,et al.  Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative , 2001, Oncogene.

[57]  H. Wiley,et al.  Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. , 2001, Molecular biology of the cell.

[58]  Xuan Sun,et al.  Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1 , 2001, Molecular and Cellular Biology.

[59]  A. Zilberstein,et al.  Phenylephrine protects neonatal rat cardiomyocytes from hypoxia and serum deprivation-induced apoptosis , 2000, Cell Death and Differentiation.

[60]  E. Lucchinetti,et al.  β-Adrenergic Receptor Subtypes Differentially Affect Apoptosis in Adult Rat Ventricular Myocytes , 2000 .

[61]  J. Tschopp,et al.  TRAIL receptor-2 signals apoptosis through FADD and caspase-8 , 2000, Nature Cell Biology.

[62]  R. Lefkowitz,et al.  The β2-Adrenergic Receptor Mediates Extracellular Signal-regulated Kinase Activation via Assembly of a Multi-receptor Complex with the Epidermal Growth Factor Receptor* , 2000, The Journal of Biological Chemistry.

[63]  H. Band,et al.  The Evolutionarily Conserved N-terminal Region of Cbl Is Sufficient to Enhance Down-regulation of the Epidermal Growth Factor Receptor* , 2000, The Journal of Biological Chemistry.

[64]  A Ciechanover,et al.  Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. , 1999, Molecular cell.

[65]  D. Lauffenburger,et al.  Internalized Epidermal Growth Factor Receptors Participate in the Activation of p21 ras in Fibroblasts* , 1999, The Journal of Biological Chemistry.

[66]  J. Brugge,et al.  Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers , 1999, Molecular and Cellular Biology.

[67]  Pulkki,et al.  Cardiomyocyte apoptosis and progression of heart failure to transplantation , 1999, European journal of clinical investigation.

[68]  Z. Kam,et al.  c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. , 1998, Genes & development.

[69]  M. Lai,et al.  Mitogen-activated Protein Kinase Kinase Antagonized Fas-associated Death Domain Protein–mediated Apoptosis by Induced FLICE-inhibitory Protein Expression , 1998, The Journal of experimental medicine.

[70]  D. Pimentel,et al.  Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. , 1998, Circulation.

[71]  W. Langdon,et al.  EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene , 1997, Oncogene.

[72]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[73]  S. Schmid,et al.  Control of EGF Receptor Signaling by Clathrin-Mediated Endocytosis , 1996, Science.

[74]  N. Bishopric,et al.  Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. , 1996, The Journal of biological chemistry.

[75]  C. McCulloch,et al.  Serum deprivation induces apoptotic cell death in a subset of Balb/c 3T3 fibroblasts. , 1994, Journal of cell science.

[76]  L. Minichiello,et al.  Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF‐dependent mitogenic signals. , 1993, The EMBO journal.

[77]  Sheila M. Thomas,et al.  Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases , 1992, Nature.

[78]  T. Pawson,et al.  The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC‐gamma. , 1990, The EMBO journal.

[79]  M. Moran,et al.  Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. , 1990, Science.

[80]  W. Wharton,et al.  Stabilized complexes of epidermal growth factor and its receptor on the cell surface stimulate RNA synthesis but not mitogenesis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[81]  S. Houser,et al.  Isolation and morphology of calcium-tolerant feline ventricular myocytes. , 1983, The American journal of physiology.

[82]  T. Littlewood,et al.  Cell death and survival signalling in the cardiovascular system. , 2012, Frontiers in bioscience.

[83]  P. Delafontaine,et al.  β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo. , 2012, Journal of molecular and cellular cardiology.

[84]  C. Rohlicek,et al.  Nuclear β-adrenergic receptors modulate gene expression in adult rat heart. , 2011, Cellular signalling.

[85]  J. Violin,et al.  Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. , 2007, The Journal of clinical investigation.

[86]  J. Molkentin,et al.  STRESS signaling pathways that modulate cardiac myocyte apoptosis. , 2005, Journal of molecular and cellular cardiology.

[87]  R. Lefkowitz,et al.  The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. , 2000, The Journal of biological chemistry.

[88]  E. Lucchinetti,et al.  Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. , 2000, Circulation.

[89]  S. Keyse,et al.  Tyrosine kinase inhibition: an approach to drug development. , 1995, Human & experimental toxicology.